Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(21,785 reports matching your criteria)
  • Veterinary Vaccines

    ... CAGR of 5.6% over the analysis period 2024-2030. Porcine Vaccines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$4.7 Billion by the end of the analysis ... Read More

  • Human Vaccines

    ... CAGR of 7.3% over the analysis period 2024-2030. Intramuscular & Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$58.7 Billion by the end of ... Read More

  • Anticoagulants

    ... 9.2% over the analysis period 2024-2030. NOACs, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$33.4 Billion by the end of the analysis period. Growth in ... Read More

  • Alopecia Drugs

    ... CAGR of 5.5% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis ... Read More

  • Antioxidants

    ... 5.7% over the analysis period 2024-2030. Synthetic Antioxidants, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More

  • Artificial Pancreas Device Systems

    ... 2030, growing at a CAGR of 18.8% over the analysis period 2024-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is expected to record a 18.8% CAGR and reach US$1.2 Billion ... Read More

  • Aseptic Processing

    ... CAGR of 3.5% over the analysis period 2024-2030. Vials & Ampoules Packaging, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$51.3 Billion by the end of ... Read More

  • Automotive Camshaft

    ... CAGR of 4.4% over the analysis period 2024-2030. Forged Camshaft, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.4 Billion by the end of the analysis ... Read More

  • Bioactive Materials

    ... CAGR of 9.0% over the analysis period 2024-2030. Glass Material, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$3.2 Billion by the end of the analysis ... Read More

  • Blood Pressure Transducers

    ... at a CAGR of 5.7% over the analysis period 2024-2030. Disposable Transducers, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$512.1 Million by the end of ... Read More

  • Botanical Supplements

    ... CAGR of 8.0% over the analysis period 2024-2030. Spices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$22.3 Billion by the end of the analysis period. ... Read More

  • Burn Care

    ... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More

  • Cable Modem Termination System (CMTS) and Converged Cable Access Platform (CCAP)

    ... at US$7.1 Billion in the year 2024, is expected to reach US$12.1 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. CCAP, one of the segments analyzed in the report, ... Read More

  • Ceramic Textiles

    ... CAGR of 8.3% over the analysis period 2024-2030. RCF Fiber, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$160.7 Million by the end of the analysis ... Read More

  • Cervical Pillows

    ... CAGR of 5.4% over the analysis period 2024-2030. Standard Pillows, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More

  • Clinical Data Analytics

    ... at a CAGR of 34.4% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$32.6 Billion by the end of ... Read More

  • Cold Pressed Juices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Organic Cold Pressed Juices, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.3 Billion by the ... Read More

  • Complex-Oxide Nanomaterials

    ... CAGR of 11.9% over the analysis period 2024-2030. Lithium Titanate, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More

  • GMO Testing

    ... CAGR of 7.0% over the analysis period 2024-2030. Stacked Trait Testing, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$2.6 Billion by the end of the ... Read More

  • Healthcare Mobility Solutions

    ... at a CAGR of 18.9% over the analysis period 2024-2030. Mobile Devices, one of the segments analyzed in the report, is expected to record a 17.6% CAGR and reach US$120.5 Billion by the end of ... Read More

  • Hemophilia Drugs

    ... CAGR of 5.5% over the analysis period 2024-2030. Hemophilia A Drugs, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$21.3 Billion by the end of the ... Read More

  • Herpes Marker Testing

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More

  • Photography Equipment

    ... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More

  • Polyphenols

    ... 7.2% over the analysis period 2024-2030. Functional Beverages Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. ... Read More

  • Sexual Enhancers

    ... CAGR of 7.7% over the analysis period 2024-2030. Male Sexual Enhancers, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$354.9 Million by the end of the ... Read More

Cookie Settings